A member produces two identical products with the active ingredient Curcuma longa, Longvida—one version in New Zealand and one in Australia. The Australian version can make the claim that it "decreases mild joint aches and pains and relieves inflammation", whereas the New Zealand - labelled product can only say "promotes general health and wellbeing". So these are some of the restrictions that we're finding our own New Zealand producers under. So I get that we need to do it properly but I also do understand that when we're setting regulations in this country, yes, it's important that they are appropriate to the country; however, there's a lot of world—we're one of the only countries in the OECD that don't have one of these regulatory regimes, and so there is plenty of information that we can call on as this has been put together. 